Unknown

Dataset Information

0

Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.


ABSTRACT: Voltage-gated sodium (NaV) channels are pore-forming transmembrane proteins that play essential roles in excitable cells, and they are key targets for antiepileptic, antiarrhythmic, and analgesic drugs. We implemented a heterobivalent design strategy to modulate the potency, selectivity, and binding kinetics of NaV channel ligands. We conjugated ?-conotoxin KIIIA, which occludes the pore of the NaV channels, to an analogue of huwentoxin-IV, a spider-venom peptide that allosterically modulates channel gating. Bioorthogonal hydrazide and copper-assisted azide-alkyne cycloaddition conjugation chemistries were employed to generate heterobivalent ligands using polyethylene glycol linkers spanning 40-120 Å. The ligand with an 80 Å linker had the most pronounced bivalent effects, with a significantly slower dissociation rate and 4-24-fold higher potency compared to those of the monovalent peptides for the human NaV1.4 channel. This study highlights the power of heterobivalent ligand design and expands the repertoire of pharmacological probes for exploring the function of NaV channels.

SUBMITTER: Peschel A 

PROVIDER: S-EPMC7667638 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.

Peschel Alicia A   Cardoso Fernanda C FC   Walker Andrew A AA   Durek Thomas T   Stone M Rhia L MRL   Braga Emidio Nayara N   Dawson Philip E PE   Muttenthaler Markus M   King Glenn F GF  

Journal of medicinal chemistry 20201020 21


Voltage-gated sodium (Na<sub>V</sub>) channels are pore-forming transmembrane proteins that play essential roles in excitable cells, and they are key targets for antiepileptic, antiarrhythmic, and analgesic drugs. We implemented a heterobivalent design strategy to modulate the potency, selectivity, and binding kinetics of Na<sub>V</sub> channel ligands. We conjugated μ-conotoxin KIIIA, which occludes the pore of the Na<sub>V</sub> channels, to an analogue of huwentoxin-IV, a spider-venom peptide  ...[more]

Similar Datasets

| S-EPMC3315629 | biostudies-literature
| S-EPMC4327855 | biostudies-literature
| S-EPMC3207152 | biostudies-literature
| S-EPMC6276078 | biostudies-literature
2021-04-16 | GSE172185 | GEO
| S-EPMC6768053 | biostudies-literature
| S-EPMC4116129 | biostudies-literature
| S-EPMC3437034 | biostudies-literature
| S-EPMC6005695 | biostudies-literature
| S-EPMC6032918 | biostudies-literature